Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients (TACAC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by Baylor Breast Care Center
Sponsor:
Collaborator:
Baylor College of Medicine
Information provided by (Responsible Party):
Baylor Breast Care Center
ClinicalTrials.gov Identifier:
NCT00206518
First received: September 14, 2005
Last updated: November 18, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2016
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)